Suchergebnisse - (Person:"De Meyer, Sandra")

PubPharm (7)

1

Genotypic and phenotypic characterization of influenza A viral variants in study participants treated with pimodivir in the phase 2b TOPAZ study

enthalten in: Antiviral therapy | 2023

von Vingerhoets, J. | Van Dromme, I. | van Duijnhoven, W. | +3

2

Assessment of etravirine resistance in HIV-1-infected paediatric patients using population and deep sequencing : final results of the PIANO study

enthalten in: Antiviral therapy | 2016

von Tambuyzer, L. | Thys, K. | Hoogstoel, A. | +5

3

Assessment of etravirine resistance in HIV-1-infected paediatric patients using population and deep sequencing: final results of the PIANO study

enthalten in: Antiviral therapy | 2015

von Tambuyzer, L. | Thys, K. | Hoogstoel, A. | +5

4

Virological analysis of once-daily and twice-daily darunavir/ritonavir in the ODIN trial of treatment-experienced patients

enthalten in: Antiviral therapy | 2013

von Lathouwers, E. | De La Rosa, G. | Van de Casteele, T. | +4

5

Virological characterization of patients failing darunavir/ritonavir or lopinavir/ritonavir treatment in the ARTEMIS study : 96-week analysis

enthalten in: Antiviral therapy | 2011

von Lathouwers, E. | De Meyer, S. | Dierynck, I. | +4

6

In vitro susceptibility and virological outcome to darunavir and lopinavir are independent of HIV type-1 subtype in treatment-naive patients

enthalten in: Antiviral therapy | 2010

von Dierynck, I. | De Meyer, S. | Lathouwers, E. | +5

7

Efficacy and safety of darunavir/ritonavir in treatment-experienced HIV type-1 patients in the POWER 1, 2 and 3 trials at week 96

enthalten in: Antiviral therapy | 2009

von Arastéh, K. | Yeni, P. | Pozniak, A. | +7

1
[1]